US Patent 10576133 BCMA chimeric antigen receptors
Patent 10576133 was granted and assigned to Bluebird Bio on March, 2020 by the United States Patent and Trademark Office.
All edits
Edits on 11 Dec, 2023
Golden AI
Edits made to:
Article (+120 characters)
Article
Patent abstract
The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.
Edits on 4 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Kevin Friedman0
Richard Morgan0
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
105761330
Date of Patent
March 3, 2020
0Patent Application Number
165029660
Date Filed
July 3, 2019
0Patent Citations
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 1 Feb, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
US Patent 10576133 BCMA chimeric antigen receptors
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10576133
Date of patent
March 3, 2020
Patent application number
16502966
Date Filed
July 3, 2019
Patent citations
Patent primary examiner
Find more entities like US Patent 10576133 BCMA chimeric antigen receptors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
